SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-01-502610
Filing Date
2001-09-14
Accepted
2001-09-14 00:00:00
Documents
7
Period of Report
2001-09-05
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w53253e8-k.htm 8-K 11269
3 PRESS RELEASE w53253ex99-1.htm EX-99.1 9040
4 SEPTEMBER 2001 NOTE PURCHASE AGREEMENT w53253ex99-2.htm EX-99.2 101742
5 ALLONGE TO 4% CONVERTIBLE SENIOR NOTE w53253ex99-3.htm EX-99.3 10914
6 CONVERTIBLE NOTE w53253ex99-4.htm EX-99.4 42918
7 CONVERTIBLE NOTE w53253ex99-5.htm EX-99.5 42771
8 FIRST AMENDMENT TO INVESTOR RIGHTS AGREEMENT w53253ex99-6.htm EX-99.6 12424
  Complete submission text file 0000950133-01-502610.txt   233439
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 1737396
SIC: 2836 Biological Products, (No Diagnostic Substances)